Vickers Venture Partners plans $500m fund targeting biotech and AI
Singapore-based angel investment firm, Vickers Venture Partners, have revealed that they are looking to raise their largest fund to date.
Singapore-based angel investment firm, Vickers Venture Partners, have revealed that they are looking to raise their largest fund to date. With an estimate of $500 million to take place later in the year, the firm is looking to increase their investment in biotechnology, artificial intelligence and nanotechnology. With $500 million being touted as the amount they are looking to raise, this will be one of the largest venture capital funds ever to be raised in Southeast Asia.
“It’s not so soon but we are soft-marketing right now, looking for anchor investors for our new fund,” Finian Tan, Chairman of Vickers Venture Partners recently told Reuters.
The recent focus on biotechnology, nanotechnology and AI is a slight change of direction for the firm but Tan explained: “In these three mega trends, if you follow them and invest in them, the growth will be exponential.” He also added that biotechnology was by far the best-perfomring sector in their portfolio, managing to achieve a multiple of more than 10 times for the firm.